Crystal Structure of the Tetrameric Cytidine Deaminase from Bacillus Subtilis at 2.0 A Resolution
Overview
Affiliations
Cytidine deaminases (CDA, EC 3.5.4.5) are zinc-containing enzymes in the pyrimidine salvage pathway that catalyze the formation of uridine and deoxyuridine from cytidine and deoxycytidine, respectively. Two different classes have been identified in the CDA family, a homodimeric form (D-CDA) with two zinc ions per dimer and a homotetrameric form (T-CDA) with four zinc ions per tetramer. We have determined the first structure of a T-CDA from Bacillus subtilis. The active form of T-CDA is assembled of four identical subunits with one active site apiece. The subunit of D-CDA is composed of two domains each exhibiting the same fold as the T-CDA subunits, but only one of them contains zinc in the active site. The similarity results in a conserved structural core in the two CDA forms. An intriguing difference between the two CDA structures is the zinc coordinating residues found at the N-terminal of two alpha-helices: three cysteine residues in the tetrameric form and two cysteine residues and one histidine residue in the dimeric form. The role of the zinc ion is to activate a water molecule and thereby generate a hydroxide ion. How the zinc ion in T-CDA surrounded with three negatively charged residues can create a similar activity of T-CDA compared to D-CDA has been an enigma. However, the structure of T-CDA reveals that the negative charge caused by the three ligands is partly neutralized by (1) an arginine residue hydrogen-bonded to two of the cysteine residues and (2) the dipoles of two alpha-helices.
Cytidine deaminases catalyze the conversion of (,)-substituted pyrimidine nucleosides.
Urbeliene N, Tiskus M, Tamulaitiene G, Gasparaviciute R, Lapinskaite R, Jauniskis V Sci Adv. 2023; 9(5):eade4361.
PMID: 36735785 PMC: 9897663. DOI: 10.1126/sciadv.ade4361.
Maiti A, Hedger A, Myint W, Balachandran V, Watts J, Schiffer C Nat Commun. 2022; 13(1):7117.
PMID: 36402773 PMC: 9675756. DOI: 10.1038/s41467-022-34752-1.
The current toolbox for APOBEC drug discovery.
Grillo M, Jones K, Carpenter M, Harris R, Harki D Trends Pharmacol Sci. 2022; 43(5):362-377.
PMID: 35272863 PMC: 9018551. DOI: 10.1016/j.tips.2022.02.007.
The Role of APOBECs in Viral Replication.
Xu W, Byun H, Dudley J Microorganisms. 2020; 8(12).
PMID: 33266042 PMC: 7760323. DOI: 10.3390/microorganisms8121899.
The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?.
Frances A, Cordelier P Mol Ther. 2019; 28(2):357-366.
PMID: 31870623 PMC: 7001087. DOI: 10.1016/j.ymthe.2019.11.026.